[10] Nintendo's iconic "cross" design was developed by Ichiro Shirai and first used the 1982 Game & Watch handheld adaptation of the Donkey Kong arcade game
doi: 10.3390/ph3061949 8 AkhtarS
Dose escalation timing directly affects how quickly adaptation occurs
The FDA simultaneously launched a dedicated compliance webpage for telehealth companies promoting compounded drugs, signaling this is now a sustained priority - not a one-time action
The Next Challenge May Be Clinical Trial Capacity Over the past few years, few drug classes have reshaped both medicine and the pharmaceutical market as dramatically as GLP-1 receptor agonists
A systematic review and meta-analysis of 57 studies of 7 classes of non-insulin antihyperglycemic agents, when considered together, concluded that compared with placebo adjunctive therapies resulted in significant reductions in A1C, body weight, and insulin dose, but also identified potential risks of hypoglycemia (risk ratio [RR], 1.04), gastrointestinal side effects (RR, 1.99), and ketoacidosis (RR, 3.44) [81]
